Despite its small diagnosed patient population, Alpha-1 Foundation has invested more than $76 million in research and programs as it vows to find a cure for Alpha-1 antitrypsin deficiency, a condition that can result in serious lung and liver disease. Foundation leaders like to say they fight outside their weight class and credit Blackbaud healthcare solutions for their outsized impact.
Ready to power your passion?
Request a customized demo to see how Blackbaud is made for your unique challenges and needs.
All fields required
Thank you for your inquiry.
A Blackbaud representative will be in touch with you shortly.
Prefer to chat now?
Click here if you’d like to speak directly to a Blackbaud representative, today.